InvestorsHub Logo
Followers 62
Posts 7601
Boards Moderated 1
Alias Born 01/02/2003

Re: dogn post# 376014

Friday, 04/29/2022 8:53:35 PM

Friday, April 29, 2022 8:53:35 PM

Post# of 428668
More patient event studies are needed on the effects of Vascepa on cancers, Alzheimers, arthritides, dry eyes,diabetes, hypertension, depression, obesity, etc.

Who will do these studies?.....certainly not generic companies....Amarin does not have the assets to do these studies....perhaps Big Pharma can do at least some of them.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News